Loading...
Symbols:
Loading...
Symbols:
Tongjitang Chinese Medicines (TCM)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Tongjitang Chinese Medicines (TCM)
53 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on TCM
- ChinaBio Today(28)
- The Sun(6)
- Centient Biotech Investor(5)
- Timothy Roe(5)
- Cabeza Howe(3)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(538)
- Stockerblog (158)
- ChinaBio Today(56)
- Michael McDonough(34)
- The Sun(10)
Most commented on authors
- The Sun(33)
- Cabeza Howe(19)
- ChinaBio Today(8)
- Bespoke Investment Group(5)
- Stockerblog (4)
- China Bio in Review: More Fallout from Economic Crisis
- Tongjitang Shares React Well to Buyback News
- China Bio in Review: Broad Themes and Deals
- China Biopharma Week in Review: Broad Views, Individual Companies
- Tongjitang Announces Buyback in Effort to Create Excitement
- Tongjitang Chinese Medicine: Earnings Up, But Counterfeits Hurt Sales
- Six Key Chinese Healthcare ADRs
- China ADRs: Mixed July
- China Biomedical Industry Evolving
- China ADRs: Severe Loss in June
- Tongjitang Slides After Buyout Offer Withdrawn
- China ADRs: Mixed May
- China Biotech Week in Review: Earnings, Deals and Drug Development
- Tongjitang Chinese Medicines Blames Weather for Disappointing Q1
- Following the China Biopharma Beat
- Two Positive Announcements from Tongjitang Chinese Medicines
- China Biopharma Growth Metrics
- China Earthquake Shuts Tongjitang Medicines Facility Down
- China Stocks: April Was Kind
- China Stocks: Still No Sign of a Bottom
- Consolidation and Growth in China Biotech
- Morgan Stanley to Evaluate Buyout Offer for Tongjitang; Investors Approve
- China Biotech in Review: Approvals, Deals and Company News
- New Product Purchases May Light Fire Under Tongjitang's Stock Price
- Tongjitang Chinese Medicines: Finding Value in China
- Earnings and More in China Biotech Weekly Review
- Tongjitang Chinese Medicines: CEO Buyout Offer Blunts Effect of Disappointing Report
- Chinese Stocks Listed in U.S. Posted Mixed February
- Winter Storms Hit Tongjitang Chinese Medicines
- China Biotech Week in Review: East-West Interdependence in 2007
- Earnings Quality Key for China Pharma Investors
- Reviewing A Good Week for China BioPharma Investment
- Investors Vote 'No Confidence' in TCM's Management
- Tongjitang Chinese Medicines Drops Sharply on Earnings, Downgrade
- Tongjitang Chinese Medicines: Fighting Off Counterfeiters
- Tongjitang Chinese Medicines's Key Drug Flat in Q3
- It's More than Just Baidu: 51 Other Ways to Invest in China
- Tongjitang's Osteoperosis Drug Likely to Win FDA Approval
- Tongjitang Wants To Go West With Osteoporosis Drug
- 12 Reasons I Believe In TCM
- Tongjitang Chinese Medicines to Seek FDA Approval for Osteoporosis Treatment
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »